Instituto de Infectologia Emilio Ribas CRS

Site Details


Avenida Doutor Arnaldo, 165

Segundo Andar – Hospital Dia Sao Paulo

Sao Paulo, 01246-900

Get Directions



CRS Coordinator

Tamara Souza


CRS Leader

Luiz Carlos Pereira Jr.


Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.